SPECIFIC LINKS TO INTEGRATED SHIELD PLANS (IPs) AND IP RIDER COVERAGE OF CANCER DRUG TREATMENTS AND SERVICES

About Us

LIA

Role

Vision, Mission, Values

Key Milestones

Management Committee

LIA Members

Membership

Member Companies

Industry Guidelines

Overview

Distribution Channels

Health Insurance

Industry Practices

Insurance Culture and Conduct Steering Committee (ICCSC)

Integrated Shield Plan (IP)

Moratorium on Genetic Testing and Insurance

Products

Technology

Consumers

Overview

Getting Started

Choosing Right

Making A Claim

When Things Go Wrong

Tools and Resources

CompareFIRST

Consumer Guides

External Links

Frequently Asked Questions

Illustrated Investment Rate of Return for Par Policies

Insurance Terms

Legacy Planning

LIA Claims Interest Rates

Life Insurance Calculator

News Room

CPF Investment Scheme Reports

Financial Sector News

Industry Performance

Letters / Speeches

Media Releases

Newsletter

For Members

Members' Circulars

Members' Undertakings

Members' Circulars (Inforce)

Members' Undertakings (Repealed)

Minutes of Management Committee Meetings

Contact Us

Member Login

SPECIFIC LINKS TO INTEGRATED SHIELD PLANS (IPs) AND IP RIDER COVERAGE OF CANCER DRUG TREATMENTS AND SERVICES

03 Feb 2023

More details on IPs and IP rider coverage of cancer drug treatments and services can be found in the respective IP Insurer’s webpage.

Insurers URLs_IPs and IP Riders.pdf

(PDF, 0.20MB)